MedPath

IDROP, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Clinical Study to Assess the Efficacy and Safety of SED80 for Use in Cataract Surgery

Phase 2
Completed
Conditions
Cataract in Inflammatory Ocular Disorders
Interventions
Drug: Dexamethasone Dose 1
Drug: Dexamethasone Dose 2
Drug: Placebo Dose 1
Drug: Placebo Dose 2
First Posted Date
2021-01-15
Last Posted Date
2021-01-15
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT04711213
Locations
🇸🇻

Centre De. Oftalmologia, San Salvador, El Salvador

A Clinical Study to Assess the Efficacy and Safety of Dexamethasone Suspension for Cataract Surgery

Phase 1
Completed
Conditions
Inflammation Eye
Interventions
First Posted Date
2018-09-27
Last Posted Date
2019-05-24
Lead Sponsor
iDrop, Inc.
Target Recruit Count
60
Registration Number
NCT03687931
Locations
🇺🇸

Arizona Eye Center, Chandler, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath